Ensign Peak Advisors
ICVX

Ensign Peak Advisors’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Ensign Peak Advisors’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,760
Closed -$33K – 2372
2022
Q2 		$33K Buy
5,760
+4,420
+330% +$34.5K ﹤0.01% 2100
2022
Q1 		$9K Buy
+1,340
New +$21.1K ﹤0.01% 2192

Other funds holding ICVX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ensign Peak Advisors's ICVX Position: Q3 2022 in Review

Ensign Peak Advisors sold out of Icosavax, Inc. Common Stock (ICVX) in Q3 2022, closing a stake of 5,760 shares — an estimated $33K sold.

Ensign Peak Advisors first reported a position in ICVX in Q1 2022 and held it in 2 quarters. The position peaked at $33K in Q2 2022. 73 funds tracked by Wall St. Rank hold ICVX as of Q3 2022.

  • Ensign Peak Advisors reported no remaining Icosavax, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 5,760 Icosavax, Inc. Common Stock shares in Q3 2022, an estimated $33K.
  • Ensign Peak Advisors first reported a position in Icosavax, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Ensign Peak Advisors's Icosavax, Inc. Common Stock position peaked at $33K in Q2 2022.
  • 73 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q3 2022.

Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.